Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Antovic

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Journal of Clinical Medicine|December 11, 2025
Multicenter Evaluation of Different Anti-Xa Assays and Diluted Russell's Viper Venom Time in Ex Vivo Plasma Samples from Patients Treated with Rivaroxaban or ApixabanMojca Božič Mijovski, Alenka Mavri, Jovan P Antovic, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 9, 2013
Obesity and thrombin-generation profiles in women with venous thromboembolismKristina Sonnevi, Svetlana N Tchaikovski, Margareta Holmström, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 25, 2024
Global Hemostatic Methods to Tailor Treatment With Bypassing Agents in Hemophilia A With Inhibitors- A Single-Center, Pilot StudyRoza Chaireti, Nida Soutari, Margareta Holmström, et al.
Annals of Clinical Biochemistry|September 23, 2015
Diluted thrombin time reliably measures low to intermediate plasma dabigatran concentrationsMojca Božič-Mijovski, Rickard E Malmström, Petra Malovrh, et al.
Mediterranean Journal of Hematology and Infectious Diseases|November 29, 2017
Correlation to FVIII:C in Two Thrombin Generation Tests: TGA-CAT and INNOVANCE ETPMarcus Ljungkvist, Maria Berndtsson, Margareta Holmström, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 10, 2003
Thrombin activatable fibrinolysis inhibitor and hemostatic changes in patients with type I diabetes mellitus with and without microvascular complicationsJovan P Antovic, Marianne Yngen, Claes-Göran G Ostenson, et al.
International Journal of Laboratory Hematology|June 29, 2011
On-demand but not prophylactic treatment with FVIII concentrate increase thrombin activatable fibrinolysis inhibitor activation in severe haemophilia A patientsD Mikovic, B J Woodhams, M Holmström, et al.
Thrombosis Research|March 7, 2017
Evaluation of a diagnostic algorithm for Heparin-Induced ThrombocytopeniaMaria Farm, Tamam Bakchoul, Tony Frisk, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|July 15, 2021
Predictive Ability of a Clinical-Genetic Risk Score for Venous Thromboembolism in Northern and Southern European PopulationsEduardo Salas, Maria Farm, Sara Pich, et al.
Thrombosis and Haemostasis|April 27, 2012
Two global haemostatic assays as additional tools to monitor treatment in cases of haemophilia AJovan P Antovic, Danijela Mikovic, Ivo Elezovic, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Journal of Clinical Medicine|December 11, 2025
Multicenter Evaluation of Different Anti-Xa Assays and Diluted Russell's Viper Venom Time in Ex Vivo Plasma Samples from Patients Treated with Rivaroxaban or ApixabanMojca Božič Mijovski, Alenka Mavri, Jovan P Antovic, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 9, 2013
Obesity and thrombin-generation profiles in women with venous thromboembolismKristina Sonnevi, Svetlana N Tchaikovski, Margareta Holmström, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 25, 2024
Global Hemostatic Methods to Tailor Treatment With Bypassing Agents in Hemophilia A With Inhibitors- A Single-Center, Pilot StudyRoza Chaireti, Nida Soutari, Margareta Holmström, et al.
Annals of Clinical Biochemistry|September 23, 2015
Diluted thrombin time reliably measures low to intermediate plasma dabigatran concentrationsMojca Božič-Mijovski, Rickard E Malmström, Petra Malovrh, et al.
Mediterranean Journal of Hematology and Infectious Diseases|November 29, 2017
Correlation to FVIII:C in Two Thrombin Generation Tests: TGA-CAT and INNOVANCE ETPMarcus Ljungkvist, Maria Berndtsson, Margareta Holmström, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 10, 2003
Thrombin activatable fibrinolysis inhibitor and hemostatic changes in patients with type I diabetes mellitus with and without microvascular complicationsJovan P Antovic, Marianne Yngen, Claes-Göran G Ostenson, et al.
International Journal of Laboratory Hematology|June 29, 2011
On-demand but not prophylactic treatment with FVIII concentrate increase thrombin activatable fibrinolysis inhibitor activation in severe haemophilia A patientsD Mikovic, B J Woodhams, M Holmström, et al.
Thrombosis Research|March 7, 2017
Evaluation of a diagnostic algorithm for Heparin-Induced ThrombocytopeniaMaria Farm, Tamam Bakchoul, Tony Frisk, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|July 15, 2021
Predictive Ability of a Clinical-Genetic Risk Score for Venous Thromboembolism in Northern and Southern European PopulationsEduardo Salas, Maria Farm, Sara Pich, et al.
Thrombosis and Haemostasis|April 27, 2012
Two global haemostatic assays as additional tools to monitor treatment in cases of haemophilia AJovan P Antovic, Danijela Mikovic, Ivo Elezovic, et al.
Pageof 5